Form 4: Director Karen McGinnis Receives RSU Grant at iRhythm
Statement of Changes in Beneficial Ownership
Director Karen McGinnis was granted 1,573 restricted stock units as part of iRhythm Holdings, Inc.'s equity compensation program.
Summary
- Director Karen McGinnis acquired 1,573 restricted stock units (RSUs) on May 27, 2026.
- Each RSU represents a contingent right to receive one share of iRhythm Holdings, Inc. (IRTC) common stock.
- The grant vests on the earlier of one year from the grant date or the date of the next annual meeting.
- Following this transaction, the director's total beneficial ownership is 3,608 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in nature.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- None identified.
Risks
- Standard market risks associated with equity ownership in a publicly traded medical technology company.
Future Outlook
The RSUs are subject to standard vesting conditions, aligning the director's interests with the company's performance over the next year.
Management Comments
- None provided.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the medical device and digital health sectors to ensure board members maintain a vested interest in company performance.
Comparison to Industry Standards
- The grant of RSUs to directors is consistent with standard corporate governance practices for mid-cap healthcare technology firms.
- Vesting schedules of one year or the next annual meeting are typical for director compensation packages in the U.S. market.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Director Karen McGinnis authorized company officers to file Section 16 reports on her behalf. | 05/26/2026 | Administrative efficiency for regulatory compliance. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation event.
Next Steps
- Vesting of the 1,573 RSUs on the earlier of May 27, 2027, or the date of the next annual meeting.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Holding company reorganization date. |
| 05/26/2026 | Execution date of Power of Attorney by Karen McGinnis. |
| 05/27/2026 | Date of RSU grant transaction. |
| 05/29/2026 | Filing date of the Form 4. |
Keywords
iRhythm, IRTC, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.